Literature DB >> 18163185

Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomas.

Remy Guillevin1, Carole Menuel, Hugues Duffau, Michel Kujas, Laurent Capelle, Agnès Aubert, Sophie Taillibert, Ahmed Idbaih, Joan Pallud, Giovanni Demarco, Robert Costalat, Khê Hoang-Xuan, Jacques Chiras, Jean-Noel Vallée.   

Abstract

The aim of the study was to investigate the ability of (1)HMRS to reflect proliferative activity of diffuse low-grade gliomas (WHO grade II). Between November 2002 and March 2007, a prospective study was performed on consecutive patients with suspected supratentorial hemispheric diffuse low-grade tumors. All the patients underwent MR examination using uniform procedures, and then surgical resection or biopsy within 2 weeks of the MR examination. Proliferative activity of the tumors was assessed by Ki-67 immunochemistry (Mb-1) on paraffin embedded tumor sections. Spectroscopic data was compared with Ki-67 labeling index and other histologic data such as histological subtype, cellular atypia, cellular density using univariate and multivariate analysis. 82 of 97 consecutive patients had histologically confirmed WHO grade 2 gliomas. Ki-67 proliferation index (PI) was correlated with specific spectral patterns: (1) low PI (<4%) was associated with increased Cho/Cr and absence of both free lipids or lactates; (2) intermediate PI (4-8%) was associated with resonance of lactates; and (3) high PI (>8%) was characterized by a resonance of free lipids. On multivariate analysis, resonance of lactates and resonance of free lipids appeared as independent predictors of intermediate PI (P < 0.001) and high PI (P < 0.001), respectively; moreover, free lipids resonance was correlated with cellular atypia (P < 0.05). This study suggests that (1)HMRS is a reliable tool to evaluate the proliferation activity of WHO grade 2 glioma and to identify potentially more aggressive clinical behavior.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18163185     DOI: 10.1007/s11060-007-9508-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  46 in total

Review 1.  Non-invasive methods for studying brain energy metabolism: what they show and what it means.

Authors:  G J Kemp
Journal:  Dev Neurosci       Date:  2000 Sep-Dec       Impact factor: 2.984

Review 2.  The potential of proton magnetic resonance spectroscopy ((1)H-MRS) in the diagnosis and management of patients with brain tumors.

Authors:  Xavier Leclerc; Thierry A G M Huisman; A Gregory Sorensen
Journal:  Curr Opin Oncol       Date:  2002-05       Impact factor: 3.645

3.  MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.

Authors:  L Neder; B O Colli; H R Machado; C G Carlotti; A C Santos; L Chimelli
Journal:  Clin Neuropathol       Date:  2004 Nov-Dec       Impact factor: 1.368

4.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Authors:  Michael H Lev; Yelda Ozsunar; John W Henson; Amjad A Rasheed; Glenn D Barest; Griffith R Harsh; Markus M Fitzek; E Antonio Chiocca; James D Rabinov; Andrew N Csavoy; Bruce R Rosen; Fred H Hochberg; Pamela W Schaefer; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

5.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; T Hirai; T Okuda; Y Shigematsu; L Liang; Y Ge; Y Ushio; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1998-12       Impact factor: 3.959

6.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

7.  Human brain tumors: assessment with in vivo proton MR spectroscopy.

Authors:  D Ott; J Hennig; T Ernst
Journal:  Radiology       Date:  1993-03       Impact factor: 11.105

8.  Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.

Authors:  K Hoang-Xuan; L Capelle; M Kujas; S Taillibert; H Duffau; J Lejeune; M Polivka; E Crinière; Y Marie; K Mokhtari; A F Carpentier; F Laigle; J M Simon; P Cornu; P Broët; M Sanson; J Y Delattre
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

9.  Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.

Authors:  Ji Hoon Shin; Ho Kyu Lee; Byung Duk Kwun; Jin-Suh Kim; Weechang Kang; Choong Gon Choi; Dae Chul Suh
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

10.  Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.

Authors:  K Onda; R L Davis; M Shibuya; C B Wilson; T Hoshino
Journal:  Cancer       Date:  1994-10-01       Impact factor: 6.860

View more
  12 in total

1.  Current Management of Adult Diffuse Infiltrative Low Grade Gliomas.

Authors:  Emilie Le Rhun; Sophie Taillibert; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

Review 2.  New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach.

Authors:  Hugues Duffau; Luc Taillandier
Journal:  Neuro Oncol       Date:  2014-08-02       Impact factor: 12.300

3.  Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.

Authors:  Fumiyuki Yamasaki; Kaoru Kurisu; Yoshinori Kajiwara; Yosuke Watanabe; Takeshi Takayasu; Yuji Akiyama; Taiichi Saito; Ryosuke Hanaya; Kazuhiko Sugiyama
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

4.  [Magnetic resonance spectroscopy of brain tumors].

Authors:  P Ditter; E Hattingen
Journal:  Radiologe       Date:  2017-06       Impact factor: 0.635

5.  Quantitative MR imaging and spectroscopy of brain tumours: a step forward?

Authors:  Dita Wagnerova; Vit Herynek; Alberto Malucelli; Monika Dezortova; Josef Vymazal; Dusan Urgosik; Martin Syrucek; Filip Jiru; Antonin Skoch; Robert Bartos; Martin Sames; Milan Hajek
Journal:  Eur Radiol       Date:  2012-06-12       Impact factor: 5.315

6.  Comparison of multiple parameters obtained on 3T pulsed arterial spin-labeling, diffusion tensor imaging, and MRS and the Ki-67 labeling index in evaluating glioma grading.

Authors:  H Fudaba; T Shimomura; T Abe; H Matsuta; Y Momii; K Sugita; H Ooba; T Kamida; T Hikawa; M Fujiki
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-03       Impact factor: 3.825

7.  Quantitative PET imaging of tryptophan accumulation in gliomas and remote cortex: correlation with tumor proliferative activity.

Authors:  Csaba Juhász; Diane C Chugani; Geoffrey R Barger; William J Kupsky; Pulak K Chakraborty; Otto Muzik; Sandeep Mittal
Journal:  Clin Nucl Med       Date:  2012-09       Impact factor: 7.794

8.  Low-grade gliomas in adults.

Authors:  Sandeep Mittal; Mark C Szlaczky; Geoffrey R Barger
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

9.  Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.

Authors:  R Guillevin; C Menuel; S Taillibert; L Capelle; R Costalat; L Abud; C Habas; G De Marco; K Hoang-Xuan; J Chiras; J-N Vallée
Journal:  Br J Cancer       Date:  2011-05-24       Impact factor: 7.640

Review 10.  Advanced MR imaging of gliomas: an update.

Authors:  Hung-Wen Kao; Shih-Wei Chiang; Hsiao-Wen Chung; Fong Y Tsai; Cheng-Yu Chen
Journal:  Biomed Res Int       Date:  2013-06-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.